TW358027B - Topical anti-inflammatory comositions containing piroxicam - Google Patents

Topical anti-inflammatory comositions containing piroxicam

Info

Publication number
TW358027B
TW358027B TW083110639A TW83110639A TW358027B TW 358027 B TW358027 B TW 358027B TW 083110639 A TW083110639 A TW 083110639A TW 83110639 A TW83110639 A TW 83110639A TW 358027 B TW358027 B TW 358027B
Authority
TW
Taiwan
Prior art keywords
inflammatory
comositions
topical anti
piroxicam
composition
Prior art date
Application number
TW083110639A
Other languages
English (en)
Inventor
Chung-Teck Shin
Luc Bossuyt
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of TW358027B publication Critical patent/TW358027B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
TW083110639A 1994-01-14 1994-11-16 Topical anti-inflammatory comositions containing piroxicam TW358027B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/181,510 US5436241A (en) 1994-01-14 1994-01-14 Topical anti-inflammatory compositions containing piroxicam

Publications (1)

Publication Number Publication Date
TW358027B true TW358027B (en) 1999-05-11

Family

ID=22664576

Family Applications (1)

Application Number Title Priority Date Filing Date
TW083110639A TW358027B (en) 1994-01-14 1994-11-16 Topical anti-inflammatory comositions containing piroxicam

Country Status (14)

Country Link
US (1) US5436241A (zh)
JP (1) JPH07206680A (zh)
CN (1) CN1088587C (zh)
BG (1) BG63031B1 (zh)
BR (1) BR9500206A (zh)
CZ (1) CZ10295A3 (zh)
GR (1) GR1002351B (zh)
HU (1) HU225896B1 (zh)
MY (1) MY114860A (zh)
PH (1) PH31650A (zh)
PL (1) PL177710B1 (zh)
RU (1) RU2138266C1 (zh)
TW (1) TW358027B (zh)
ZA (1) ZA949250B (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO379596A0 (en) 1996-11-22 1996-12-19 Soltec Research Pty Ltd Percutaneous delivery system
KR100288190B1 (ko) * 1998-02-09 2001-04-16 김용규 피록시캄 함유 알콜성 하이드로겔 조성물
FR2797766B1 (fr) * 1999-08-27 2003-04-04 Menarini France Nouvelles formes topiques a consistance pateuse sous forme d'un gel distribue en doses
JP4108271B2 (ja) * 2000-12-21 2008-06-25 花王株式会社 ゲル状化粧料
US20060067958A1 (en) * 2004-09-24 2006-03-30 Unilab Pharmatech, Ltd. Pharmaceutical topical gel compositions
US8221046B2 (en) 2005-02-25 2012-07-17 Johnson & Johnson Consumer Companies, Inc. Compositions containing amines and use thereof
US8278359B2 (en) * 2005-02-25 2012-10-02 Johnson & Johnson Consumer Companies, Inc. Compositions containing amines and use thereof to treat acne or reduce the appearance of oil or pores on the skin
US20060193814A1 (en) 2005-02-25 2006-08-31 Eduardo Ruvolo Compositions for the treatment of signs of aging
MX2007009796A (es) * 2007-08-14 2009-02-25 Cell Therapy And Technology S Gel conteniendo pirfenidona.
US20090227683A1 (en) * 2008-03-06 2009-09-10 Liebel Frank T Compositions for Providing an Analgesic Effect to the Skin
CA2719512A1 (en) 2010-11-01 2012-05-01 Stiefel Research Australia Pty Ltd Polymeric topical compositions
MX357376B (es) * 2011-06-22 2018-07-06 Laboratorios Senosiain S A De C V Star Composicion farmaceutica para uso en inflamacion y dolor.
DE102013215828A1 (de) * 2013-08-09 2015-02-12 Beiersdorf Ag Gelförmiges Sonnenschutzmittel mit Fettalkoholen
KR102324870B1 (ko) * 2014-11-13 2021-11-09 주식회사 엘지생활건강 난용성 성분을 안정화한 화장료 조성물
US10744174B1 (en) * 2016-03-16 2020-08-18 Robert Alonso Composition(s) and method(s) for topically treating pain

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
JPS5913714A (ja) * 1982-07-13 1984-01-24 Taito Pfizer Kk 外用消炎鎮痛剤
LU84941A1 (fr) * 1983-08-02 1985-04-24 Oreal Nouveaux composes polyanioniques derives d'arylethers de polyglycerols
US4582831A (en) * 1984-11-16 1986-04-15 Pfizer Inc. Anti-inflammatory polymorphic monoethanolamine salt of N-(2-pyridyl)-2-methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide compound, composition, and method of use therefor
KR890001236B1 (ko) * 1985-10-02 1989-04-28 화이자 인코포레이티드 소염제 조성물의 제조방법
US5081118A (en) * 1987-10-26 1992-01-14 Pfizer Inc. Benzothiazine dioxide derivatives
JPH0347134A (ja) * 1989-03-08 1991-02-28 Hoechst Japan Ltd ヒドロゲル製剤およびキセロゲル製剤の製造法

Also Published As

Publication number Publication date
CZ10295A3 (en) 1995-09-13
PH31650A (en) 1999-01-12
CN1111128A (zh) 1995-11-08
PL306795A1 (en) 1995-07-24
BR9500206A (pt) 1995-10-17
RU2138266C1 (ru) 1999-09-27
JPH07206680A (ja) 1995-08-08
CN1088587C (zh) 2002-08-07
PL177710B1 (pl) 2000-01-31
HUT73635A (en) 1996-08-28
ZA949250B (en) 1995-07-14
US5436241A (en) 1995-07-25
BG99352A (bg) 1995-09-29
MY114860A (en) 2003-02-28
HU225896B1 (en) 2007-12-28
GR1002351B (el) 1996-05-29
HU9500112D0 (en) 1996-05-28
BG63031B1 (bg) 2001-02-28

Similar Documents

Publication Publication Date Title
TW358027B (en) Topical anti-inflammatory comositions containing piroxicam
CA2164050A1 (en) Cosmetic compositions containing betulinic acid
ATE269054T1 (de) Konfekt zusammensetzungen
HU9401105D0 (en) Low ph aqueous cosmetic gel containing non-ionic polyacrylamide derivatives
ZA985030B (en) Composition for use in personal care.
EP0533937A4 (en) Acidic hair dye composition
CA2179778A1 (en) Deuterised active agents in transdermal application
IT8249563A0 (it) Composizioni e preparazioni farmaceutiche ad attivita' dermatologica in particolare per attenuare la sintomatologia dovuta a eczema, psoriasi, herpes simplex e simili
IT1299197B1 (it) Composizione ad attivita' antiossidante, antiproliferativa, energetica e atta a migliorare l'utilizzazione metabolica del glucosio.
ZA949874B (en) B3-adrenergic agents, benzodioxole dicarboxylates and their use in pharmaceutical compositions.
AU6285390A (en) Improvements in or relating to i.c. engines
IT8620607A0 (it) Composizioni elestomeriche fluide, reticolabili all'umidita'ambientale, adatte per l'uso in sigillanti.
MY125552A (en) Synergistic personal hygiene process
NZ503700A (en) Agrochemical compositions that include alkylsaccharide surfactants
DE69625804D1 (en) Aus aloe barbadensis isoliertes cinnamoyl-c-glykosid chromon
AU7482994A (en) Use of added water to achieve 100 per cent injection weight in geothermal operations
HRP930833B1 (en) Water soluble retinoids
ZA981839B (en) Sunscreen compositions containing damaged rna fragments
Shakhlamov et al. Ultrastructure of entero-endocrine system cells in choleragen intoxication of rats.
ITFO930009U3 (it) dispositivo per l'azionamento del meccanismo di regolazione dello schienale nelle poltrone per ufficio.
ITRM920045A1 (it) Composizioni farmaceutiche ad attivita' anti-aging.
Weiss Flat-Rolled(U. S. Market) Should Be Okay in85
Woo et al. Hybridization Between Chochicine Induced Asiatic species and Normal Plant in Cotton
Vaillancourt The bootstrap and its adaptation to Klein's Model I
Sugaya M. Kimura: Why Japan Closed Its Doors; The Price Revolution in the Pan-Pacific, 1600-1650